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A
Abstract
Background: Fenestration in the modified Fontan operation allows right-to-left shunting, which reduces the Fontan path-
way pressure and improves cardiac output. However, on account of the fact that persistent right-to-left shunting results in 
cyanosis and paradoxical emboli, fenestration closure is recommended after recovery from the Fontan operation.
Methods: This study recruited 3 patients who underwent the transcatheter closure of the Fontan fenestration with the 
ASD-Amplatzer because of severe cyanosis and significant intracardiac shunts.
Results: Fenestration closure was performed at a mean age of 8 yr (6-12 yr) and average of 15 months after the Fontan 
operation. Aortic O2 saturation increased by an average of 17.6% (9-26%). During more than a two-year period of follow-up 
(mean: 27 months), two patients had complete occlusion on echocardiography and the other one had a small residual shunt. 
One of these patients had atrial flutter during the follow-up. 
Conclusion: The transcatheter closure of the Fontan fenestration is a safe and feasible technique that is effective in elevat-
ing systemic O2 saturation and well-being and confers acceptable growth and development in children.
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Introduction 
The Fontan operation, performed for the first time by 
Francis Fontan in 1968, has undergone many a modification 
over the years.1-6 Fenestration in the Fontan pathway allows 
right-to-left shunting, which lowers the Fontan pathway 
pressure and improves cardiac output and short-term clinical 
outcome in the standard risk population.6-13 Nevertheless, 
persistent right-to-left shunting between the neo-right atrium 
and neo-left atrium begets cyanosis and increases the risk of 
paradoxical embolism.6,8
Fenestration closure is, therefore, recommended after 
recovery from the Fontan operation.9,14 Several devices such 
as the Coi1 and Amplatzer have thus far been utilized for 
fenestration closure. We safely used the ASD-Amplatzer for 
the transcatheter closure of the Fontan fenestration.
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Methods
A total of three patients have undergone the transcatheter 
closure of the Fontan fenestration at Rajaei Hospital in 
Tehran since 2003. These patients had persistent systemic 
desaturation and no signs of increased systemic venous 
pressure or low cardiac output such as hepatomegaly, ascites 
or edema. The patients’ mean age at the time of fenestration 
closure was 8 yr (6-12 yr). The subjects’ characteristics are 
listed in Table 1. All the patients tolerated the intracardiac 
Fontan operation with pericardial patch tunnel well. One 
case had a 12-mm fenestration due to technical error in 
surgery, and the other two had 5-mm and 6-mm punch-hole 
fenestrations.
 The patients’ medical records were reviewed to determine 
their demographic, echocardiographic, hemodynamic and 
angiographic data.



















Case Sex Type of congenital heart disease 















12y 5 mm 9 mm No Residue 
2 Female DMGA, DORV, 
VSD, PS 
6y As above 6y,2m 12 mm 17 mm Small Residue 
3 male Single ventricle, 
LTGA, DILV, PS 
4y As above 6y 6 mm 12 mm No Residue 
PS, Pulmonary stenosis; D-MGA, DMalposition of great arteries; DORV, Double outlet right ventricle; VSD, Ventricular septal defect; LTGA, L-Transposition 
of great arteries; DILV, Double inlet left ventricle
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 The presence of residual shunts after fenestration closure 
was evaluated via angiography and serial echocardiography. 
After discharge, a clinical follow-up was carried out at a 
mean of 27 months.
Transthoracic echocardiography was performed before 
cardiac catheterization to detect possible thrombi and to 
evaluate patent fenestrations. Arterial and venous collaterals 
were assessed via angiograms at the aorta, superior vena cava 
or innominate vein and pulmonary artery. Before fenestration 
closure with the ASD-Amplatzer, a test occlusion of the 
fenestration with an ASD-sizing balloon was performed. 
About 15-20 minutes after the test occlusion, the changes in 
pressure and O2 saturation within the Fontan pathway were 
measured. The criteria for fenestration closure6,14-17 were: 
1. Right atrial pressure≤18mmHg
2. Difference of the arteriovenous O2 saturation≤33%
3. Right atrial saturation≥40% 
4. Increase in the mean RA pressure<4mmHg  
If the changes in pressure and cardiac output were acceptable, 
a suitable ASD-Amplatzer according to the fenestration size was 
implanted. Heparin was administered during the procedure and 
warfarin thereafter for thrombus prophylaxis. The differences in 
O2 saturation pre- and post-fenestration closure and outpatient 
clinical follow-up are reported.
Results
Three patients, who tolerated a modified Fontan operation 
with fenestration and met the criteria for fenestration closure, 
were selected. The ASD-Amplatzer was utilized safely, and 
there were no complications during more than two years of 
follow-up.
Table 2 depicts the O2 saturation data at the femoral artery 
before and after fenestration closure. Aortic O2 saturation 
increased by an average of 17.6% (9-26%). During the 
clinical follow-up, two patients had complete occlusion of 
the fenestration on serial echocardiography; and the other 
one, who had a 12-mm fenestration due to technical error 
in surgery, had a small residual shunt. One of the cases had 
atrial flutter after the Fontan operation, which was controlled 
with anti-arrhythmic drugs during the clinical follow-up. 
The data on pressure changes in the Fontan pathway before 
and after the procedure are presented in Table 3. The mean 
pressure in the Fontan circuit increased by an average of 2.7 
mmHg (Range: 2-3.6 mmHg). After fenestration closure, the 
mean pressure in the Fontan circuit increased in all of the 
patients.
Table 2. O2 Saturation before and after fenestration closure (arterial blood 
gas and pulse oximetry)
Case Before procedure After procedure at catheterism lab
The latest follow-up 
at clinic 
1 66% 92% 90%
2 76% 85% 87%
3 72% 90% 89%
Table 3. Pressure changes in Fontan circuit before and after fenestration 
closure (mmHg)
Case Before procedure After procedure Change
1 9.2 12.8 ↑3.6
2 10.1 12.1 ↑2
3 8.8 11.3 ↑2.5
None of the patients had a significant change in O2 
saturation during more than two years of follow-up after 
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Growth and development of the patients was acceptable 
during the follow-up according to the growth & development 
standard charts.
After the Fontan operation, all the patients received 
warfarin for anti-thrombotic prophylaxis. Warfarin was 
continued after fenestration closure in these patients. None 
of the patients had symptomatic thromboembolism within 
the follow-up period. Serial transthoracic echocardiography 




Although fenestration in the Fontan procedure can 
improve the immediate postoperative course, it may give 
rise to persistent cyanosis and paradoxical embolism. There 
has long been debate in the medical community over the 
advisability of fenestration closure; more recent reports, 
however, advocate the procedure.6,17-20
 Goff et al.21 reported that not only did fenestration closure 
confer improved oxygenation but it also reduced the need 
for anti-congestive medication and improved somatic 
growth. They recommended that patients with the Fontan 
fenestration procedure undergo late transcatheter closure 
(>6 months after Fontan) if O2 saturation rates were less 
than 90% and test occlusion was tolerated. The good results 
that we had previously achieved in the ASD occlusion with 
the Amplatzer in children encouraged us to opt for the 
transcatheter occlusion of the Fontan fenestration with the 
ASD-Amplatzer. Our study data demonstrate that Fontan 
fenestration closure with the Amplatzer in selected patients 
is a safe and effective procedure that can lead to an increase 
in O2 saturation. In addition, more than two years of follow-
up was indicative of acceptable growth and development, 
improved quality of life, no significant change in O2 
saturation and no symptomatic thromboembolic events in 
our three patients. We did not use Coils in this study because 
all our cases tolerated intracardiac tunnel-type Fontan. Sung 
Hye Kim et al.6 reported that punch-hole fenestration with 
intracardiac tunnel-type Fontan was not suitable for closure 
with Coils. In addition, some studies showed that Amplatzer 
duct occluders and Amplatzer septal occluders such as the 
ASD-Amplatzer were suitable for fenestration closure.2,18-20 
In our study, two cases had a standard fenestration size and 
had no residual shunts after closure. However, the other 
patient, who had a 12-mm fenestration due to technical error 
in surgery, had a small residual shunt after the procedure. 
Of great significance is the fact that in all our patients O2 
saturation after fenestration closure increased significantly 
without any complications. One patient had atrial flutter after 
the procedure, but it was not a result of fenestration closure.
It is deserving of note that after the Fontan operation atrial 
arrhythmia is reported frequently.22 In some studies, the 
difference in O2 saturation between early after fenestration 
closure and the latest follow-up visit is significant. This 
difference is believed to be caused by the reopening of the 
fenestration.6 In the present study, there was no difference in 
O2 saturation between the early and late follow-up visits of 
our three patients, which was probably due to the complete 
occlusion of the fenestration with the ASD-Amplatzer and 
the superior efficacy of the Amplatzer in comparison with 
the Coil.
Conclusion
The transcatheter closure of the Fontan fenestration with the 
ASD-Amplatzer is a safe and feasible technique in selected 
patients, especially in those that can tolerate transient closure 
with sizing balloons before permanent closure with the ASD-
Amplatzer.
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